gillem-tulloch
asia
biostime
51job-jobs-us
kuangchi-science
fake-cash-flow
smc-corporation
china-shengmu-organic-milk-ltd-1432-hk
sino-biopharm
imperial-pacific-international-holdings-ltd-1076-hk
luye-pharma
huabao-international-holdings-ltd-0336-hk
silicon-motion
changyou-dot-com-ltd-cyou-us
bep
new-provenance
nihon-parkerizing
dr-lal-pathlabs-ltd-dlpl-in
tarena-international-inc
wipro
a2-milk-atm-nz-a2m-au
united-energy-group
yirendai-ltd
upl-ltd
gemdale-properties-and-investment-corporation-ltd-0535-hk
mitsubishi-pencil
china-lesso-group-holdings-2128-hk
balkrishna-industries-bil-in
pilot-corp
kulicke-and-soffa
ramkhamhaeng-hospital
dongjiang-environment-co-ltd-0895-hk
oceanagold-corp
tube-investments-india
china-goldjoy
china-oceanwide--holdings-0715-hk
sk-kaken-co
sinopec-kantons
Insights
1 December, 2023
NEWSLETTER: EVERGRANDE (3333 HK)
Never profitable

Fredrik Oeqvist
Evergrande’s much delayed and recently published 2021 annual report makes clear that it significantly overstated revenue and earnings – most likely for many years. Contrary to what some people think, Evergrande was not so much a victim of tightened liquidity or a COVID-induced property market downturn; its problems were far more fundamental – there were never any profits....
Read More
18 August, 2020
NEWSLETTER: COMING HOME?
Watch out for the privatisation “squeeze out”

Gillem Tulloch
The proposed Holding Foreign Companies Accountable Act could force hundreds of Chinese companies listed on US exchanges to delist over the next few years. For many large companies, seeking a secondary listing in Hong Kong or the mainland is a sensible insurance policy. However, investors should be wary of companies which decide to privatise and then relist. Our analysis of...
Read More